Falcigo Injection

Artesunate
60mg
Cadila Pharmaceuticals Limited.
Pack size
Dispensing mode
Source
Agent
Retail Price 373.20 NPR

Indications

Falcigo Injection is used for: Malaria, Schistosomiasis

Adult Dose

Falciparum malaria especially in quinidine-resistant patients Adult: PO: 4 mg/kg once daily x3 days (with mefloquine)

Child Dose

Renal Dose

Administration

Contra Indications

Hypersensitivity.

Precautions

Hepatic or renal insufficiency. Pregnancy and lactation. Lactation: unknown

Pregnancy-Lactation

Interactions

Antimalarial potentiating action seen with mefloquine, primaquine and tetracycline. Additive effect with chloroquine. Antagonistic effect with pyrimethamine and sulphonamides.

Adverse Effects

Side effects of Artesunate : Generally well-tolerated, Cardiotoxicity (high doses), Neurotoxicity observed in animal studies, Drug induced fever, Skin rash

Mechanism of Action

Artesunate is a potent and rapidly-acting blood schizontocide derived from the leaves of the chinese herb, Armesia annua. The exact mode of action is not clear but clinical studies have confirmed the effectiveness of artesunate in P. vivax and falciparum malaria. Unclear, may inhibit DNA replication & transcription.

Note

Falcigo 60mg Injection manufactured by Cadila Pharmaceuticals Limited.. Its generic name is Artesunate. Falcigo is availble in Nepal. Farmaco Nepal drug index information on Falcigo Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Artesunate :